Comparative effectiveness of switching antipsychotic drug treatment to aripiprazole or ziprasidone for improving metabolic profile and atherogenic dyslipidemia: A 12-month, prospective, open-label study

Yuejin Chen, William V. Bobo, Kara Watts, Karuna Jayathilake, Tinlai Tang, Herbert Y. Meltzer*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

23 Scopus citations

Fingerprint Dive into the research topics of 'Comparative effectiveness of switching antipsychotic drug treatment to aripiprazole or ziprasidone for improving metabolic profile and atherogenic dyslipidemia: A 12-month, prospective, open-label study'. Together they form a unique fingerprint.

Medicine & Life Sciences